missing translation for 'onlineSavingsMsg'
Learn More

Tocris Bioscience™ RECTAS

IKBKAP pre-mRNA splicing modulator

199.78 EUR - 764.56 EUR

Specifications

Chemical Name or Material 2-Chloro-N-(2-furanylmethyl)-7 H-purin-6-amine
CAS 101862-47-9
Target DNA, RNA and Protein Synthesis Compounds
Molecular Formula C10H8ClN5O
Purity 0.98
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18708626
View Documents Promotion Details
Tocris Bioscience™
7679/10
10 mg
199.78 EUR
10mg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
18707026
View Documents Promotion Details
Tocris Bioscience™
7679/50
50 mg
764.56 EUR
50mg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

RECTAS (rectifier of aberrant splicing) is a pre-mRNA splicing modulator of the IKBKAP (inhibitor of κ light polypeptide gene enhancer in B-cells, kinase complex associated protein) gene. It corrects aberrant IKBKAP splicing in vitro in cellular models of familial dysautonomia and in vivo in transgenic mice. In combination with Phenylbutyric acid (Cat. No. 2682), RECTAS rescues PARK7 aberrant splicing and neuronal cell loss in a midbrain organoid model of familial Parkinson's disease. Orally bioavailable and brain penetrant.
Specifications

Specifications

2-Chloro-N-(2-furanylmethyl)-7 H-purin-6-amine
DNA, RNA and Protein Synthesis Compounds
0.98
101862-47-9
C10H8ClN5O
Videos
Safety and Handling

Safety and Handling

Recommended Storage : Store at -20°C

SDS
Documents

Documents

Product Certifications